Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
Current clinical research suggests that retatrutide may produce greater average weight loss than semaglutide
MIC Plus B12 is available in our Beverly Hills and Arcadia clinics for $79 with mobile service available across Los Angeles County for $278
Tirzepatide, a dual GIP/GLP-1 receptor agonist, has shown even greater efficacy in some studies, with weight reductions of approximately 20% in the SURMOUNT-1 trial
Visible skin changes typically appear after 8-12 weeks of consistent daily supplementation
Rare case reports have described rhabdomyolysis after tirzepatide initiation
Ruan PK, Gray RJ (2008) Analyses of cumulative incidence functions via non-parametric multiple imputation
US$ 28.20
US$ 29.52
US$ 27.55
US$ 25.77
US$ 24.52
US$ 23.23
US$ 28.69
US$ 21.53
US$ 20.79
US$ 26.56
US$ 25.26
